These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 28164890)

  • 1. A new case of imatinib-induced drug reaction with eosinophilia and systemic symptoms.
    Saidi W; Lahouel I; Laarif M; Aounallah A
    Indian J Dermatol Venereol Leprol; 2017; 83(2):224-226. PubMed ID: 28164890
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug reaction with eosinophilia and systemic symptoms (DRESS) induced by imatinib in chronic myeloid leukemia.
    Vatel O; Aumont C; Mathy V; Petit M; Feriel J; Sloma I; Bennaceur-Griscelli A; Turhan AG
    Leuk Lymphoma; 2017 Feb; 58(2):473-474. PubMed ID: 27389710
    [No Abstract]   [Full Text] [Related]  

  • 3. Imatinib: muscle pain suggestive of a withdrawal syndrome.
    Prescrire Int; 2016 Mar; 25(169):70. PubMed ID: 27152402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Imatinib-induced pigmentation of the hard palate].
    Kluger N; Cassier P; Ruffion N
    Ann Dermatol Venereol; 2018 Nov; 145(11):723-724. PubMed ID: 30472997
    [No Abstract]   [Full Text] [Related]  

  • 5. Imatinib mesylate-induced interstitial lung disease in a patient with prior history of Mycobacterium tuberculosis infection.
    Lee NR; Jang JW; Kim HS; Yhim HY
    Korean J Intern Med; 2015 Jul; 30(4):550-3. PubMed ID: 26161025
    [No Abstract]   [Full Text] [Related]  

  • 6. Secondary thrombotic microangiopathy in two patients with Philadelphia-positive hematological malignancies treated with imatinib mesylate.
    Ojeda-Uribe M; Merieau S; Guillon M; Aujoulat O; Hinschberger O; Eisenmann JC; Kenizou D; Debliquis A; Veyradier A; Chantrel F
    J Oncol Pharm Pract; 2016 Apr; 22(2):361-70. PubMed ID: 25591869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful Use of Dasatinib After Liver Transplantation for Imatinib-Induced Fulminant Liver Failure in Chronic Myeloid Leukemia.
    Harding DJ; MacQuillan G; Howman R; de Boer B; Adams L; Mitchell A; Jeffrey G
    J Clin Oncol; 2016 Apr; 34(11):e97-8. PubMed ID: 25267743
    [No Abstract]   [Full Text] [Related]  

  • 8. Suspicion of fenofibrate-related drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a case report.
    Safrano L; Bourneau-Martin D; Le Clech C; Chennebault JM; Jamet A; Drablier G; Lagarce L; Lainé-Cessac P
    Therapie; 2014; 69(5):461-4. PubMed ID: 25269143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imatinib--A New Tyrosine Kinase Inhibitor for First-Line Treatment of Chronic Myeloid Leukemia in 2015.
    Gambacorti-Passerini C; Piazza R
    JAMA Oncol; 2015 May; 1(2):143-4. PubMed ID: 26181011
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia.
    Cerny-Reiterer S; Rabenhorst A; Stefanzl G; Herndlhofer S; Hoermann G; Müllauer L; Baumgartner S; Beham-Schmid C; Sperr WR; Mannhalter C; Sill H; Linkesch W; Arock M; Hartmann K; Valent P
    Oncotarget; 2015 Feb; 6(5):3071-84. PubMed ID: 25605011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Watermelon stomach: Chronic renal failure and/or imatinib?].
    Montagnac R; Blaison D; Brahimi S; Schendel A; Levasseur T; Takin R
    Nephrol Ther; 2015 Nov; 11(6):496-501. PubMed ID: 26165799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe Agranulocytosis in Two Patients with Drug-induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms.
    Kato M; Kano Y; Sato Y; Shiohara T
    Acta Derm Venereol; 2016 Aug; 96(6):842-3. PubMed ID: 27025798
    [No Abstract]   [Full Text] [Related]  

  • 13. Imatinib mesylate in chronic myeloid leukemia: frontline treatment and long-term outcomes.
    Stagno F; Stella S; Spitaleri A; Pennisi MS; Di Raimondo F; Vigneri P
    Expert Rev Anticancer Ther; 2016; 16(3):273-8. PubMed ID: 26852913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug reaction with eosinophilia and systemic symptoms due to lercanidipine.
    Slim R; Fathallah N; Larif S; Ben Salem C
    Indian J Dermatol Venereol Leprol; 2016; 82(3):324-6. PubMed ID: 27088943
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug Reaction with Eosinophilia and Systemic Symptoms or Virus Reactivation with Eosinophilia and Systemic Symptoms.
    Descamps V; Brunet-Possenti F
    Pediatr Dermatol; 2016 Sep; 33(5):562. PubMed ID: 27595878
    [No Abstract]   [Full Text] [Related]  

  • 16. Probable Griseofulvin-Induced Drug Reaction with Eosinophilia and Systemic Symptoms in a Child.
    Smith RJ; Boos MD; McMahon P
    Pediatr Dermatol; 2016 Sep; 33(5):e290-1. PubMed ID: 27397873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin-associated drug reaction with eosinophilia and systemic symptoms syndrome.
    Young S; Ojaimi S; Dunckley H; Douglas MW; Kok J; Fulcher DA; Lin MW; Swaminathan S
    Intern Med J; 2014 Jul; 44(7):694-6. PubMed ID: 25041771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dapsone-induced drug reaction with eosinophilia and systemic symptoms associated with HLA-B*13:01.
    Cai F; Lucas M; Yun J
    Intern Med J; 2018 Mar; 48(3):363-364. PubMed ID: 29512326
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe enterocolitis associated with antiepileptic-induced drug reaction with eosinophilia and systemic symptoms.
    Swanson EA; Low L; Naini BV
    Hum Pathol; 2014 Sep; 45(9):1973-7. PubMed ID: 24935058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regorafenib: Dress.
    Prescrire Int; 2015 Jan; 24(156):20-1. PubMed ID: 25729832
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.